Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.445 USD | -1.57% | -1.96% | +110.84% |
30/05 | Cantor Fitzgerald Initiates ADC Therapeutics at Overweight Rating | MT |
07/05 | HC Wainwright Adjusts Price Target on ADC Therapeutics to $8 From $9, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+110.84% | 337M | |
+16.73% | 123B | |
+13.04% | 107B | |
-5.80% | 24.01B | |
+2.62% | 22.59B | |
-10.09% | 18.16B | |
-40.52% | 16.84B | |
-14.00% | 16.23B | |
+1.18% | 13.43B | |
+24.18% | 11.32B |
- Stock Market
- Equities
- ADCT Stock
- News ADC Therapeutics SA
- Morgan Stanley Lowers ADC Therapeutics SA's Price Target to $17 From $30, Maintains Overweight Rating